2WHO, Geneva. Estimating the impact of the next influenza pandemic:enhancing preparedness [ EB/DL ] . 2004; http: //www.who.int/csr/disease/influenza/preparedness. 2004-12-08.
3Hilleman, Maurice R. Realities and enigmas of human viral influenza:pathogenesis, epidemiology and control [J] .Vaccine 2002; 20 (25-26): 3068-3087.
4Wright PF, Webster RG. Orthomyxoviruses [M] .In: Knipe DM,Howley PM, editors. Fields virology, vol. 1.4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001. p. 1533 -79.
5Snacken R, Kendal AP, Haaheim LR, Wood JM. The next influenza pandemic: lessons from Hong Kong [J] .1997. Emerg Infect Dis1999; 5: 195-203.
6Cox NJ, Subbarao K. Ifluenza [J] .Lancet 1999; 354: 1277-82.
1Chen Z, Matsuok, Asanumah, et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin-and neuraminidase-expressing DNAs. Vaccine, 1999,17(7-8) :653-659.
2Levi R, Aboud-Pirok E A, Leclerc C, et al. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine, 1995,13:1353-1359.
3John J T, Robert F B,Gale E S,et al. Evaluation of a recombinant Hemagglutinin expressed in insect cells as an influenza yaccinc in young and elderly adults. J Infect Dis, 1996,174:1467-1470.
4Parkin N T, Chiu P, Coelingh K. Genetically engineered live attenuated influenza A virus vaccine candidates. J Virol, 1997,71: 2772-2778.
5Hilbert A K, McCarthy L, Mills K H. Biodegradable microspheres containing influenza a vaccine Immune response in mice. Vaccine, 1999,17:1065-1073.
6Robert B B. A review of attenuation of influenza virus by genetic manipulation. Am J Respir Crit Med, 1995,152:72-75.
7Arnon R , Levi R. Synthetic reconbinant vaccines against viral agents. Int Arch Allergy Immunol, 1995,108: 321-326.
8Harley V R, Mather K A,Power B E,et al. Characterization of an avian influenza virus nucleoprotein expressed in E. coli and in insect cells. Arch Virol, 1990,113: 267-277.
9Mather H A, White J F, Hudson P J, et al. Expression of influenza neureminidase in baculovirus-infected cells. Virus Res, 1992,26:12715.
10Lakey D L, Treanor J, Betts R F, et al. Recombinant Baculivirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis, 1996,174:838-841.